Literature DB >> 2496361

Glycosylated and carbamylated haemoglobin in uraemia.

W G Smith1, M Holden, M Benton, C B Brown.   

Abstract

Glycosylated and carbamylated haemoglobin were determined in patients with uraemia and/or diabetes mellitus. Glycosylated haemoglobin measured by ion-exchange chromatography (HbA1, HbA1c, HbA1a + b) was elevated in non-diabetic uraemic patients, while colorimetrically determined glycosylated haemoglobin was similar to controls. Patients with diabetes mellitus and normal renal function had similar glycosylated haemoglobin concentrations to those with renal failure. Both methods showed an excellent correlation, independent of renal function, in patients with diabetes mellitus. The HbA1c component was more influenced by diabetes and the HbA1a + b component was relatively more dependent on renal function. Carbamylated haemoglobin was detected in all subjects, but was grossly elevated in uraemia. Carbamylated haemoglobin significantly correlated with renal function and chromatographically determined glycosylated haemoglobin. Data from this study strongly suggests that the apparent elevation of chromatographically determined glycosylated haemoglobin in uraemia is due to the increased formation of carbamylated haemoglobin. However, in patients with diabetes mellitus, independent of renal function, both the chromatographic and colorimetric methods of determining glycosylated haemoglobin are equally valuable and reliable. The non-enzymatic formation of carbamylated haemoglobin in uraemia has several similarities to glycosylated haemoglobin in patients with diabetes mellitus. Carbamylated haemoglobin may have a clinical role as a marker of uraemia and may also have a pathophysiological relevance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496361

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Diagnostic application of the A(1c) assay in renal disease.

Authors:  Adnan Sharif; Keshwar Baboolal
Journal:  J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 10.121

2.  Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy.

Authors:  Henrik Andreas Bergrem; Tone Gretland Valderhaug; Anders Hartmann; Jøran Hjelmesaeth; Torbjørn Leivestad; Harald Bergrem; Trond Jenssen
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 8.237

3.  Measurement of Hba(1C) in patients with chronic renal failure.

Authors:  Randie R Little; Curt L Rohlfing; Alethea L Tennill; Steven E Hanson; Shawn Connolly; Trefor Higgins; Charles E Wiedmeyer; Cas W Weykamp; Richard Krause; William Roberts
Journal:  Clin Chim Acta       Date:  2013-01-12       Impact factor: 3.786

4.  Pretransplant HbA1c Is a Useful Predictor for the Development of New-Onset Diabetes in Renal Transplant Recipients Receiving No or Low-Dose Erythropoietin.

Authors:  Kazuaki Tokodai; Noritoshi Amada; Izumi Haga; Atsushi Nakamura; Toshiaki Kashiwadate; Naoki Kawagishi; Noriaki Ohuchi
Journal:  Int J Endocrinol       Date:  2014-10-16       Impact factor: 3.257

Review 5.  Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers?

Authors:  Laëtitia Gorisse; Stéphane Jaisson; Christine Piétrement; Philippe Gillery
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

6.  Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.

Authors:  Szu-Ying Lee; Yin-Cheng Chen; I-Chieh Tsai; Chung-Jen Yen; Shu-Neng Chueh; Hsueh-Fang Chuang; Hon-Yen Wu; Chih-Kang Chiang; Hui-Teng Cheng; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.